Sunitinib is superior to interferon α with respect to quality of life for patients with renal cell carcinoma

Authors

Keywords

Journal

Volume 6, Issue 1, Pages 6-7

Publisher

Springer Nature

Online

2008-12-19

DOI

10.1038/ncponc1283

Explore over 38,000 international journals covering a vast array of academic fields.

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now